Trading Journal Initial buy was good, sell was premature ( i think general market weakness and not wanting profits to turn into breakeven, sold early), should have waited).
In the end it worked out because stock gapped lower ( luck played).
Retried buy again but weakness got me to sell the next day.
−0.001 BRL
−1.50 B BRL
12.12 B BRL
About Alnylam Pharmaceuticals, Inc.
Sector
Industry
CEO
Yvonne L. Greenstreet
Website
Headquarters
Cambridge
Founded
2002
ISIN
BRA1LNBDR003
FIGI
BBG00XV4BP79
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
ALNY, LTH & ZETA - The momentum may drive prices to new heights!Alnylam Pharmaceuticals
The stock price has encountered several rejections around the 212 level, leading to subsequent corrections.
After establishing a Double Bottom pattern, the price attempted to reverse the downward trend but was unable to do so, facing rejection at the 200 level.
Conseque
ALNY Indecision Candle w/ Tons of VolumeFound this with a volume scan on FINVIZ.
Massive indecision/high wave candle with tons of volume.
Wait for a close either above the high or below the low, and play accordingly. For example, if it closes above the high, I'd be in bullish. If it closes below the low, I'd be bearish.
Enjoy!
ALNY. Alnylam PharmaceuticalsALNY is through a corrective pullback Right now it's in a position where it can go Bullish.
But it is what I call a weak buy demand because it's 50% of the peak where it started the reversal pullback. To buy from this position, I need to see a clear reversal pattern otherwise I´ll wait for it to con
#ALNY trade plan up to 18-Aug-23Based on our team's research of the options market, we expect buy activity at the support level or sell activity at the resistance. Although the amount of money involved is not large (less thatn 1 million dollars), the size of the option position is about 50% of the typical daily volume, indicating
ALNY - 3rd Wave Could Be ImpulsiveALNY has been printing 2 corrective pattern separated waves and following an upper wicked shakeout reversal now appears to be entering a third wave that could potentially see a change up to become impulsive.
As we've seen many times now the fast wick up followed by impulsive downside is the BIG clu
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ALNY5653584
Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027Yield to maturity
−2.64%
Maturity date
Sep 15, 2027
See all A1LN34 bonds
Curated watchlists where A1LN34 is featured.